2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Esposito E et al. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. 2012 Eur J Pharm Biopharm pmid:22061262
Shah MH and Paradkar A Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. 2007 Eur J Pharm Biopharm pmid:17353118
Nielsen LH et al. Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin. 2017 Eur J Pharm Biopharm pmid:27993733
Wörle G et al. Effect of drug loading on the transformation of vesicular into cubic nanoparticles during heat treatment of aqueous monoolein/poloxamer dispersions. 2006 Eur J Pharm Biopharm pmid:16497495
Lopes LB et al. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. 2006 Eur J Pharm Biopharm pmid:16621488
Onoue S et al. Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. 2012 Eur J Pharm Biopharm pmid:22008148
Bittner B et al. The use of election paramagnetic resonance spectroscopy in early preformulation experiments: the impact of different experimental formulations on the release of a lipophilic spin probe into gastric juice. 2001 Eur J Pharm Biopharm pmid:11226824
Morsi NM et al. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. 2014 Eur J Pharm Biopharm pmid:23688805
Sallam AS et al. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate. 2002 Eur J Pharm Biopharm pmid:11976023
Esposito E et al. Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. 2014 Eur J Pharm Biopharm pmid:24361485
Carneiro C et al. DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. 2015 Eur J Pharm Biopharm pmid:25499956
Tiossi RF et al. In vitro and in vivo evaluation of the delivery of topical formulations containing glycoalkaloids of Solanum lycocarpum fruits. 2014 Eur J Pharm Biopharm pmid:24509413
Rizwan SB et al. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. 2011 Eur J Pharm Biopharm pmid:21237267
Ahmed AR and Bodmeier R Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. 2009 Eur J Pharm Biopharm pmid:18840521
Simonetti LD et al. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. 2009 Eur J Pharm Biopharm pmid:19442727
Zhu Q et al. A two-stage enzymatic process for synthesis of extremely pure high oleic glycerol monooleate. 2011 Enzyme Microb. Technol. pmid:22112823
Zawalich WS and Zawalich KC Forskolin-induced desensitization of pancreatic beta-cell insulin secretory responsiveness: possible involvement of impaired information flow in the inositol-lipid cycle. 1990 Endocrinology pmid:1691696
Zawalich WS et al. Interleukin-1 alpha exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion. 1989 Endocrinology pmid:2539976
Zawalich WS Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide. 1989 Endocrinology pmid:2544404
Sanandaji N et al. Comparison of oligonucleotide migration in a bicontinuous cubic phase of monoolein and water and in a fibrous agarose hydrogel. 2006 Electrophoresis pmid:16807936
Lopes I et al. Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibrio fischeri and Salmonella typhimurium. 2012 Ecotoxicology pmid:22314390
Costa-Balogh FO et al. Drug release from lipid liquid crystalline phases: relation with phase behavior. 2010 Drug Dev Ind Pharm pmid:19848561
Kwon TK and Kim JC Monoolein cubic phase containing acidic proteinoid: pH-dependent release. 2011 Drug Dev Ind Pharm pmid:20528616
Quiñones OG et al. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. 2014 Drug Dev Ind Pharm pmid:23826859
Réeff J et al. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases. 2013 Drug Dev Ind Pharm pmid:23078519
Montenegro L et al. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. 2011 Drug Dev Ind Pharm pmid:21204752
Dai J and Kim JC Photo responsive monoolein cubic phase containing coumarin-Tween 20 conjugates. 2013 Drug Dev Ind Pharm pmid:23902365
Helledi LS and Schubert L Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system. 2001 Drug Dev Ind Pharm pmid:11794810
Zhou Y et al. Biological artificial fluid-induced non-lamellar phases in glyceryl monooleate: the kinetics pathway and its digestive process by bile salts. 2014 Drug Dev Ind Pharm pmid:23350691
Ahirrao M and Shrotriya S In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting. 2017 Drug Dev Ind Pharm pmid:28574732
Lee J and Kellaway IW Peptide washout and permeability from glyceryl monooleate buccal delivery systems. 2002 Drug Dev Ind Pharm pmid:12455474
Patil SS et al. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. 2016 Drug Dev Ind Pharm pmid:26651381
Ganem-Quintanar A et al. Monoolein: a review of the pharmaceutical applications. 2000 Drug Dev Ind Pharm pmid:10900537
Puri V and Bansal AK In vitro-in vivo characterization of release modifying agents for parenteral sustained-release ketorolac formulation. 2004 Drug Dev Ind Pharm pmid:15285335
Okonogi S et al. Development of local injectable dental gel: the influence of certain additives on physicochemical properties of glycerylmonooleate-based formulations. 2004 Drug Dev Ind Pharm pmid:15132177
Rachmawati H et al. Curcumin nanoemulsion for transdermal application: formulation and evaluation. 2015 Drug Dev Ind Pharm pmid:24502271
Shan-Bin G et al. Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation. 2015 Drug Dev Ind Pharm pmid:24502270
Badie H and Abbas H Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation. 2018 Drug Dev Ind Pharm pmid:30095009
Eskinazi-Budge A et al. Preparation of emulsifying wax/glyceryl monooleate nanoparticles and evaluation as a delivery system for repurposing simvastatin in bone regeneration. 2018 Drug Dev Ind Pharm pmid:29847182
Peng X et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. 2015 Drug Des Devel Ther pmid:26345516
Pham AC et al. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging. 2015 Drug Deliv Transl Res pmid:26328930
Yu X et al. Melanoma therapy with transdermal mitoxantrone cubic phases. 2016 Drug Deliv pmid:25835224
Aboud HM et al. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. 2018 Drug Deliv pmid:29869515
Zawalich WS et al. The effect of monooleoylglycerol on insulin secretion from isolated perifused rat islets. 1989 Diabetologia pmid:2668083
Timmers KI et al. Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. 1990 Diabetes pmid:1977650
Bhatt AB et al. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization. 2015 Curr Drug Deliv pmid:25176029
Maurya L et al. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization. 2018 Curr Drug Deliv pmid:29629662
Komnick H et al. Is monoacylglycerol as an intermediate of triacylglycerol digestion absorbed by Aeshna cyanea larvae? 1996 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:8761172
Amar-Yuli I and Garti N Transitions induced by solubilized fat into reverse hexagonal mesophases. 2005 Colloids Surf B Biointerfaces pmid:15921902
Esposito E et al. Monoolein liquid crystalline phases for topical delivery of crocetin. 2018 Colloids Surf B Biointerfaces pmid:30015140